In coordination with DoH J.P. Morgan's Life Sciences Private Capital announces Life Sciences Innovation Summit 2024 finalists ahead of ADGHW
05 Apr 2024
ABU DHABI, UAE, April 5, 2024 /PRNewswire/ -- Taking place on the sidelines of Abu Dhabi Global Healthcare Week (ADGHW), hosted by the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, J.P. Morgan Asset Management's Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group announce the 11 finalists of the inaugural Life Sciences Innovation Summit 2024 on May 14 – 15, 2024.
Continue Reading
Preview
Source: PRNewswire
Healthcare Innovation (PRNewsfoto/The Department of Health – Abu Dhabi)
The finalists were selected from a pool of exceptional candidates across more than 20 countries and represent a diverse range of companies and research institutions developing innovative therapeutic solutions. Each finalist has demonstrated a commitment to advancing healthcare through creativity and groundbreaking research, with the ultimate goal of addressing unmet patient needs for diseases of prevalence in the Middle East.
Finalists selected to compete in the summit include:
Algen Biotechnologies, Chun-Hao Huang, PhD, Co-Founder & CEO
AnaCardio, Patrik Strömberg, PhD, CEO
Chimera Therapeutics, Matthew Lorence, PhD, Co-Founder & CEO
Harmonic Discovery, Rayees Rahman, PhD, CEO
Lactocore, Anton Malyshev, PhD, Founder & CEO
Medicovestor, Seah Lim, PhD, CEO
Oncoheroes Biosciences, Cesare Spadoni, PhD, Co-Founder & Chief Operating Officer
Paradox Immunotherapeutics, Natalie Galant, PhD, Co-Founder & CEO
SaudiVax, Mazen Hassanain, PhD, CEO
Ypsilon Therapeutics, Dongxing Zha, PhD, Founder & CEO
ZTI Biosciences, Jaden Hyungseok Chang, PhD, CEO
Stephen Squinto, PhD, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital said: "We are very pleased to be partnering with the stellar leadership of the Department of Health – Abu Dhabi, Blue Horizon Advisors, United AlSaqer Group, Cleveland Clinic Abu Dhabi and other local leaders in launching our inaugural innovation summit."
Nabil Kobeissi, Chief Executive Officer, Blue Horizon Advisors added
: "We are grateful to these preeminent scientists and business leaders for coming to Abu Dhabi to experience our growing innovation hub and meet these stellar finalists. With over 150 highly qualified applications submitted from around the globe, clearly the medical research and innovation community is paying attention to this event."
Dr. Asma Al Mannaei, the Executive Director of Research and Innovation Centre at the Department of Health – Abu Dhabi (DoH) said: "The hosting of the J.P. Morgan Asset Management Life Sciences Innovation Summit 2024 on the sidelines of Abu Dhabi Global Healthcare Week reflects the Department's dedication to transforming the regional healthcare ecosystem and accelerating innovation and healthcare outcomes. The Department of Health –
Abu Dhabi takes immense pride in fostering a disruptive environment where bright minds, researchers and innovators can bring forth groundbreaking solutions and treatments that contribute to the health and well-being of community members in Abu Dhabi and beyond. Abu Dhabi Global Healthcare Week aims to bring together innovators, investors and industry leaders to explore the latest advancements and trends shaping the future of healthcare. Reinforcing Abu Dhabi's position as a leading destination for life sciences and innovation, we look forward with excitement to ADGHW as we are confident it will mark a valuable starting point to a new era of collaboration with leading international partners on the global healthcare stage."
The finalists will be judged by an esteemed panel, which includes:
Laurie Glimcher, MD, President and CEO at Dana-Farber Cancer InstituteCancer Institute
Jorge Guzman, MD, CEO at Cleveland Clinic Abu Dhabi
Prof. Shahrukh Khurshid Hashmi, Director of Research at Department of Health, Abu Dhabi
David Hung, MD, Founder, President and CEO at Nuvation Bio
Yasmine Hayek Kobeissi, PhD, CQF, BSc., Executive Director at Blue Horizon Advisors
Anya Schiess, Managing Partner at J.P. Morgan Life Sciences Private Capital
In addition to the pitch competition, the summit will feature keynote speeches and networking opportunities to provide attendees with investment opportunities and valuable insights into the future of life sciences innovation. Learn more about the finalists and summit here.
ADGHW is a major government initiative from DoH held on 13th-15th May 2024, under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council. The event seeks to accelerate collaboration, innovation, and investment, and bring together researchers, policymakers, healthcare specialists, investors, and entrepreneurs across the global healthcare and life-science ecosystem.
Photo - https://mma.prnewswire.com/media/2380078/Healthcare_Innovation.jpg
SOURCE The Department of Health - Abu Dhabi
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.